Arbutus Biopharma Corporation Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Arbutus Biopharma Corporation stock downgraded to Sell Candidate
(Updated on Apr 18, 2024)
The Arbutus Biopharma Corporation stock price fell by -1.80% on the last day (Thursday, 18th Apr 2024) from $2.78 to $2.73. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79. The price has fallen in 7 of the last 10 days and is down by -9% for this period. Volume has increased on the last day by 308 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 988 thousand shares were bought and sold for approximately $2.70 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.73% during the next 3 months and, with a 90% probability hold a price between $2.94 and $3.61 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ABUS Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arbutus Biopharma Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.90 and $2.74. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -12.50%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Arbutus Biopharma Corporation stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.54 and $2.49. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Arbutus Biopharma Corporation finds support just below today's level at $2.54. If this is broken, then the next support from accumulated volume will be at $2.49 and $2.38.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 3.72%. For the last week, the stock has had daily average volatility of 4.40%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ABUS) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Arbutus Biopharma Corporation to open at $2.74, and during the day (based on 14 day Average True Range), to move between $2.58 and $2.88, which gives a possible trading interval of +/-$0.145 (+/-5.33%) up or down from last closing price. If Arbutus Biopharma Corporation takes out the full calculated possible swing range there will be an estimated 10.66% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.92 (6.96%) than the support at $2.54 (6.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Arbutus Biopharma Corporation stock A Buy?
The Arbutus Biopharma Corporation stock holds several negative signals and despite the positive trend, we believe Arbutus Biopharma Corporation will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -3.120 Sell Candidate Downgraded
Predicted Opening Price for Arbutus Biopharma Corporation of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $2.74 ( 0.244%) | $2.73 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ABUS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.84 | 3.91 % | |
| R2 | 2.80 | 2.51 % | ||
| R1 | 2.77 | 1.64 % | ||
| Current price: | 2.73 | |||
| Support | S1 | 2.70 | -1.16 % | |
| S2 | 2.67 | -2.02 % | ||
| S3 | 2.64 | -3.42 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.12 | 14.29 % | |
| R2 | 3.00 | 9.89 % | ||
| R1 | 2.92 | 6.96 % | ||
| Current price | 2.73 | |||
| Support | S1 | 2.54 | -6.96% | |
| S2 | 2.49 | -8.79% | ||
| S3 | 2.38 | -12.82% |
FAQ
Click here for our free guide on how to buy Arbutus Biopharma Corporation Stock.
